These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15725381)

  • 1. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes.
    Duthie MS; Cetron MS; Van Voorhis WC; Kahn SJ
    Acta Trop; 2005 Mar; 93(3):317-29. PubMed ID: 15725381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
    Millar AE; Kahn SJ
    Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen.
    Millar AE; Kahn SJ
    Infect Immun; 2000 Jun; 68(6):3574-80. PubMed ID: 10816514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family.
    Santos MA; Garg N; Tarleton RL
    Mol Biochem Parasitol; 1997 May; 86(1):1-11. PubMed ID: 9178263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS
    Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages.
    Risso MG; Garbarino GB; Mocetti E; Campetella O; Gonzalez Cappa SM; Buscaglia CA; Leguizamon MS
    J Infect Dis; 2004 Jun; 189(12):2250-9. PubMed ID: 15181573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
    Chuenkova M; Pereira ME
    J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: monoclonal antibodies to the surface glycoprotein superfamily differentiate subsets of the 85-kDa surface glycoproteins and confirm simultaneous expression of variant 85-kDa surface glycoproteins.
    Kahn SJ; Nguyen D; Norsen J; Wleklinski M; Granston T; Kahn M
    Exp Parasitol; 1999 May; 92(1):48-56. PubMed ID: 10329365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
    Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
    Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cell invasion by Trypanosoma cruzi: importance of sialidase activity.
    de Titto EH; Araujo FG
    Acta Trop; 1987 Sep; 44(3):273-82. PubMed ID: 2892363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
    Tonelli RR; Torrecilhas AC; Jacysyn JF; Juliano MA; Colli W; Alves MJ
    Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
    Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
    Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional network of intramolecular cross-reacting epitopes delays the elicitation of neutralizing antibodies to Trypanosoma cruzi trans-sialidase.
    Pitcovsky TA; Buscaglia CA; Mucci J; Campetella O
    J Infect Dis; 2002 Aug; 186(3):397-404. PubMed ID: 12134236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.
    Martin DL; Weatherly DB; Laucella SA; Cabinian MA; Crim MT; Sullivan S; Heiges M; Craven SH; Rosenberg CS; Collins MH; Sette A; Postan M; Tarleton RL
    PLoS Pathog; 2006 Aug; 2(8):e77. PubMed ID: 16879036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasite-derived trans-sialidase binds to heart tissue in Trypanosoma cruzi-infected animals.
    Alcântara-Neves NM; Ribeiro-dos-Santos R; Amor AL; Uemura H; Silva-Neto SJ; Eichinger D; Pontes-de-Carvalho L
    Microb Pathog; 2004 Nov; 37(5):273-8. PubMed ID: 15519048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain.
    Vasconcelos JR; Boscardin SB; Hiyane MI; Kinoshita SS; Fujimura AE; Rodrigues MM
    Immunol Cell Biol; 2003 Apr; 81(2):121-9. PubMed ID: 12631235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.